Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug – STAT

by

  1. Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug STAT
  2. A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
  3. Eli Lilly (LLY) Weight-Loss Shot Gives Company’s Strongest Results in Trial Bloomberg
  4. Triple Agonist Retatrutide Hits New Weight-Loss Highs Medscape
  5. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
  6. View Full Coverage on Google News

Read original article here

Leave a Comment